The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 22, 2016
Filed:
Jan. 12, 2010
Santu Bandyopadhyay, Kolkata, IN;
Bikas Chandra Pal, Kolkata, IN;
Jaisankar Parasuraman, Kolkata, IN;
Siddhartha Roy, Kolkata, IN;
Jayashree Bagchi Chakrabotry, Kolkata, IN;
Indrani Choudhury Mukherjee, Kolkata, IN;
Sanjit Kumar Mahato, Kolkata, IN;
Aditya Konar, Kolkata, IN;
Srabanti Rakshit, Kolkata, IN;
Labanya Mandal, Kolkata, IN;
Dipyaman Ganguly, Kolkata, IN;
Kausik Paul, Kolkata, IN;
Anirban Manna, Kolkata, IN;
Jayaraman Vinayagam, Kolkata, IN;
Churala Pal, Kolkata, IN;
Santu Bandyopadhyay, Kolkata, IN;
Bikas Chandra Pal, Kolkata, IN;
Jaisankar Parasuraman, Kolkata, IN;
Siddhartha Roy, Kolkata, IN;
Jayashree Bagchi Chakrabotry, Kolkata, IN;
Indrani Choudhury Mukherjee, Kolkata, IN;
Sanjit Kumar Mahato, Kolkata, IN;
Aditya Konar, Kolkata, IN;
Srabanti Rakshit, Kolkata, IN;
Labanya Mandal, Kolkata, IN;
Dipyaman Ganguly, Kolkata, IN;
Kausik Paul, Kolkata, IN;
Anirban Manna, Kolkata, IN;
Jayaraman Vinayagam, Kolkata, IN;
Churala Pal, Kolkata, IN;
COUCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH, New Delhi, IN;
Abstract
The present invention relates to compounds of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention also relates to the use of compound of general formula 1 for the treatment of malignancy by inhibition of PI3-Akt pathway and or induction of NO. The present invention further relates to a method of treating malignancy by inhibition of PI3-Akt pathway and or induction of NO by administration of compound or said composition to a mammal in need thereof.